References
- L. Pottel, M. Lycke, T. Boterberg, I. Foubert, H. Pottel, F. Duprez, L. Goethals, R. Debruyne, Omega-3 fatty acids: physiology, biological sources and potential applications in supportive cancer care, Phytochemistry Reviews 13 (2013) 223–244.
- C. Calder, Omega-3 fatty acids and inflammatory processes, Nutrients 2 (2010) 355-374.
- A. Simopoulos, Omega-3 fatty acids in inflammation and autoimmune diseases, Journal of the American College of Nutrition 21 (2002) 495–505.
- C. Schacky, W.S. Harris, Cardiovascular benefits of omega-3 fatty acids, Cardiovascular Research 73 (2007) 310–315.
- G. Parker, N.A. Gibson, H. Brotchie, G. Heruc, A.M. Rees, D. Hadzi-Pavlovic, Omega-3 fatty acids and mood disorders, American Journal of Psychiatry 163 (2006) 969–978.
- J.A. Reiffel, A. McDonald, antiarrhythmic effects of omega-3 fatty acids, The American Journal of Cardiology 98 (2006) 50-60.
- G. Fernandes, J.T. Venkatraman, Role of omega-3 fatty acids in health and disease, Nutrition Research 13 (1993) S19-S45.
- B.M. Yashodhara, S. Umakanth, J.M. Pappachan, S.K. Bhat, R. Kamath, B.H. Choo, Omega-3 fatty acids: a comprehensive review of their role in health and disease, Postgraduate Medical Journal 85 (2009) 84–90.
- A. Bimbo, Sources of omega-3 fatty acids, in: Food Enrichment with Omega-3 Fatty Acids, Eds.: C. Jacobsen, N.S. Nielsen, A.F. Horn, A.D.M. Sørensen, Woodhead Publishing, Sawston, UK, pp. 27-107 (2013).
- E. Mateev, A. Irfan, A. Mateeva, M. Kondeva-Burdina, M. Georgieva, A. Zlatkov, In silico and in vitro screening of pyrrole-based hydrazidehydrazones as novel acetylcholinesterase inhibitors, Pharmacia 71 (2024) 1-7.
- G. Sliwoski, S. Kothiwale, J. Meiler, E.W. Lowe Jr., E.L. Barker, computational methods in drug discovery, Pharmacological Reviews 66 (2014) 334-395.
- T.L. Šestić, J.J. Ajduković, M.A. Marinović, E.T. Petri, M. Savić, In silico ADMET analysis of the A-, B- and D-modified androstane derivatives with potential anticancer effects, Steroids 189 (2023) 109147.
- A. Isvoran, A.A. Ciorsac, V. Ostafe, ADME-Tox profiling of some low molecular weight water soluble chitosan derivatives, ADMET & DMPK 5 (2017) 192–200.
- D. Dascălu, D.L. Roman, M. Filip, A.A. Ciorsac, V. Ostafe, A. Isvoran, Solubility and ADMET profiles of short oligomers of lactic acid, ADMET & DMPK 8 (2020) 425-436.
- D.L. Roman, M. Roman, C. Som, M. Schmutz, E. Hernandez, Wick, T. Casalini, G. Perale, V. Ostafe, A. Isvoran, Computational Assessment of the Pharmacological Profiles of Degradation Products of Chitosan, Frontiers in Bioengineering and Biotechnology, 7 (2019), Article 214
- D.L. Roman, A. Isvoran, M. Filip, V. Ostafe, M. Zinn, In silico assessment of pharmacological profile of low molecular weight oligohydroxyalkanoates, Frontiers in Bioengineering and Biotechnology, 8 (2020), Article 584010
- M. Roman, D.L. Roman, V. Ostafe, A. Ciorsac, A. Isvoran, Computational assessment of pharmacokinetics and biological effects of some anabolic and androgen steroids, Pharmaceutical Research 35 (2018) 41.
- S. Mishra, R. Dahima, In vitro ADME studies of tug-891, a gpr-120 inhibitor using Swiss ADME predictor, Journal of Drug Delivery and Therapeutics 9 (2019) 266-369.
- J.G. Mvondo, A. Matondo, D.T. Mawete, S.M.N. Bambi, B.M. Mbala, O. Lohohola, In silico ADME/T properties of quinine derivatives using SwissADME and pkCSM Webservers, International Journal of Tropical Disease & Health 42 (2021) 1-12.
- D. Ranjith, C. Ravikumar, SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Ipomoea mauritiana Jacq, Journal of Pharmacognosy and Phytochemistry 8 (5) (2019) 2063-2073
- A. Daina, O. Michielin, V. Zoete, SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules, Scientific Reports 7 (2017) 42717.
- C.A. Lipinski, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discovery Today: Technologies 1 (2004) 337-341
- C.A. Lipinski, F. Lombardo, B.W. Dominy, J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews 46 (2001) 3–26.
- A.K. Ghose, V.N. Viswanadhan, J.J. Wendoloski, A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases, Journal of Combinatorial Chemistry 1 (1999) 55–68.
- D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, K.D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, Journal of Medicinal Chemistry 45 (2002) 2615–2623.
- W.J. Egan, K.M. Merz, J.J. Baldwin, Prediction of drug absorption using multivariate statistics, Journal of Medicinal Chemistry 43 (2000) 3867–3877.
- I. Muegge, S. L. Heald and D. Brittelli, Simple Selection Criteria for Drug-like Chemical Matter, Journal of Medicinal Chemistry 44 (2001) 1841–1846
- G. Xiong, Z. Wu, J. Yi, L. Fu, Z. Yang, C. Hsieh, M. Yin, X. Zeng, C. Wu, A. Lu, X. Chen, T. Hou, D. Cao, ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic Acids Research 49 (2021) W5–W14.
- J. Dong, N. Wang, Z. Yao, L. Zhang, Y. Cheng, D. Ouyang, A. Lu, D. Cao, ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database, Journal of Cheminformatics 10 (2018) 29
- L. Fu, S. Shi, J. Yi, N. Wang, Y. He, Z. Wu, J. Peng, Y. Deng, W. Wang, C. Wu, A. Lyu, X. Zeng, W. Zhao, T. Hou, D. Cao, ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support, Nucleic Acids Research 52 (2024) W422–W431.
- L.G. Ferreira, A.D. Andricopulo, ADMET modeling approaches in drug discovery, Drug Discovery Today 24 (2019) 1157-1165.
- J.A. Arnott, S.L. Planey, The influence of lipophilicity in drug discovery and design, Expert Opinion on Drug Discovery 70 (2012) 863–875.
- M.Q. Xua, T. Zhong, X. Yao, Z.Y. Li, H. Li, J.R. Wang, Z.H. Feng, X. Zhang, Effect of XlogP and Hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles, Drug Delivery 28 (2021) 1603-1615.
- S.A. Wildman, G.M. Crippen, Prediction of physicochemical parameters by atomic contributions, Journal of Chemical Information & Computer Sciences 39 (1999) 868–873.
- I. Moriguchi, S. Hirono, K. Liu, I. Nakagomi, Y. Matsushita, Simple method of calculating octanol/water partition coefficient, Chemical and Pharmaceutical Bulletin 40 (1992) 127-130.
- I. Moriguchi, S. Hirono, I. Nakagome, H. Hirano, Comparison of reliability of log p values for drugs calculated by several methods, Chemical and Pharmaceutical Bulletin 42 (1994) 976-978.
- J.S. Delaney, ESOL: Estimating aqueous solubility directly from molecular structure, Journal of Chemical Information & Computer Sciences 44 (2004) 1000–1005.
- J. Ali, Camilleri, M.B. Brown, A.J. Hutt, S.B. Kirton, Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area, Journal of Chemical Information and Modeling 52 (2012) 420–428.
- S. Kim, J. Chen, T. Cheng, A. Gindulyte, J. He, S. He, Q. Li, B.A. Shoemaker, A. Thiessen, B. Yu, L. Zaslavsky, J. Zhang, E.E. Bolton, PubChem in 2021: new data content and improved web interfaces, Nucleic Acids Research 8 (2021) 1388-1395.
- National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP), National Toxicology Program Chemical Repository Database (1992).
- W.M. Meylan, H. Howard, R.S. Boethling, Improved method for estimating water solubility from octanol/water partition coefficient, Environmental Toxicology and Chemistry 15 (1996) 100-106.
- J.A. Arnott, S.L. Planey, The influence of lipophilicity in drug discovery and design, Expert Opinion on Drug Discovery 7 (2012) 863-875.
- L.G. Herbette, ‘Pharmacokinetic’ and ‘pharmacodynamic’ design of lipophilic drugs based on a structural model for drug interactions with biological membranes, Pesticide Science 35 (1992) 363-368.
- N.F. Krebs, Bioavailability of dietary supplements and impact of physiologic state: infants, children and adolescents, The Journal of Nutrition 131 (2001) 1351S-1354S.
- L.D. Hughes, D.S. Palmer, F. Nigsch, J.B.O. Mitchell, Why are some properties more difficult to predict than others? A study of QSPR models of solubility, melting point, and Log P, Journal of Chemical Information and Modeling 48 (2008) 220-232.
- I. Yusof, M.D. Segall, Considering the impact drug-like properties have on the chance of success, Drug Discovery Today 18 (2013) 659-666.
- D.S. Wishart, Improving early drug discovery through ADME modelling, Drugs in R&D 8 (2007) 349–362.